Singapore markets close in 7 hours 15 minutes

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
50.65+0.05 (+0.10%)
At close: 4:00PM EDT

51.00 +0.35 (0.69%)
After hours: 6:08PM EDT

Full screen
Trade prices are not sourced from all markets
Previous close50.60
Open51.00
Bid49.50 x 1200
Ask51.55 x 900
Day's range49.31 - 52.75
52-week range11.65 - 75.00
Volume1,504,753
Avg. volume1,454,101
Market cap6.399B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-14.64
Earnings date12 May 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est34.67
  • GlobeNewswire

    Vir Biotechnology Announces Pricing of Public Offering of Common Stock

    SAN FRANCISCO, July 07, 2020 -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today.

  • GlobeNewswire

    Vir Biotechnology Announces Proposed Public Offering of Common Stock

    Vir Biotechnology, Inc. (VIR), a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) relating to a proposed underwritten public offering of 6,200,000 shares of its common stock. In addition, Vir expects to grant the underwriters a 30-day option to purchase up to 930,000 additional shares of its common stock offered at the public offering price, less the underwriting discounts and commissions. The public offering price has not yet been determined.

  • Here's Why Vir Biotechnology Jumped 12% in May
    Motley Fool

    Here's Why Vir Biotechnology Jumped 12% in May

    What happened Shares of Vir Biotechnology (NASDAQ: VIR) rose 12% in May, according to data provided by S&P Global Market Intelligence, after the biotech published preclinical data in the journal Nature on S309, a monoclonal antibody that appears to target SARS-CoV-2, the novel coronavirus that causes COVID-19.